ebook Munafa Stock Market Course + Intraday & FNO calls  

       

APLS announcements Apellis Pharmaceuticals, Inc. announcements and dividends declared USA

Apellis Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Apellis Pharmaceuticals, Inc. APLS

Apellis Pharmaceuticals, Inc. APLS listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Apellis Pharmaceuticals, Inc. APLS

: Apellis Pharmaceuticals stock surges after investigation finds needles are potential cause of injection side effect
Apellis Pharmaceuticals Inc. shares APLS jumped 30% premarket on Wednesday after the company identified a potential cause for a rare but serious side effect linked with its Syfovre injection for age-related macular degeneration. Structural variations were
Announcement as on 23 August 2023

Apellis Pharmaceuticals (APLS) Shares Cross Above 200 DMA
In trading on Thursday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) crossed above their 200 day moving average of .80, changing hands as high as .95 per share. Apellis Pharmaceuticals Inc shares are currently trading up about 4.1% on the da
Announcement as on 16 June 2022

Apellis Pharmaceuticals (APLS) Shares Cross Above 200 DMA
In trading on Thursday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) crossed above their 200 day moving average of .80, changing hands as high as .95 per share. Apellis Pharmaceuticals Inc shares are currently trading up about 4.1% on the da
Announcement as on 16 June 2022

Apellis Pharmaceuticals stock plunges after disappointing result from GA treatment studies
Shares of Apellis Pharmaceuticals Inc. plunged 31.6% toward a 10-month low to pace all premarket losers Friday, after one of the Phase 3 studies of the biopharmaceutical company's eye disease treatment failed to meet its primary endpoint. The company said
Announcement as on 10 September 2021

Announcements by Apellis Pharmaceuticals, Inc. first page | Prev page |

APLS Apellis Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Apellis Pharmaceuticals, Inc.

  • 5Day Average: 21.78
  • 12Day Average: 20.96
  • 20Day Average: 20.47
  • 50Day Average: 22.95
  • 100Day Average: 23.69
  • 150Day Average: 21.88
  • 200Day Average: 22.01

APLS Indicators & signals

Indicator MACD (12,26,9)

21.42, 21.63, -0.71
Indicator MACD is in negative zone

Indicator ADX (14)

24.14, 33.03, 20.18
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of APLS Apellis Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 23.62 22.02 to 24.08 6.44% 1.29 times
04 Thu Dec 2025 22.19 21.16 to 22.45 4.42% 1.26 times
03 Wed Dec 2025 21.25 20.61 to 21.32 2.86% 0.76 times
02 Tue Dec 2025 20.66 20.51 to 21.34 -2.55% 0.83 times
01 Mon Dec 2025 21.20 21.00 to 21.38 -0.47% 0.76 times
28 Fri Nov 2025 21.30 21.11 to 21.72 -1.34% 0.52 times
26 Wed Nov 2025 21.59 20.90 to 21.71 2.81% 0.9 times
25 Tue Nov 2025 21.00 19.99 to 21.14 4.32% 1.13 times
24 Mon Nov 2025 20.13 19.50 to 20.35 2.65% 2.02 times
21 Fri Nov 2025 19.61 19.40 to 19.95 0.36% 0.71 times
20 Thu Nov 2025 19.54 19.48 to 19.91 0.46% 1.12 times
19 Wed Nov 2025 19.45 19.31 to 19.83 -1.42% 0.98 times

Videos related to: APLS announcements Apellis Pharmaceuticals, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

APLS announcements Apellis Pharmaceuticals, Inc. announcements and dividends declared USA

 

Back to top